Impact of different diagnostic measures on drug class association with dementia progression risk: a longitudinal prospective cohort study
View ORCID ProfileDaman Kaur, Magda Bucholc, View ORCID ProfileDavid P. Finn, View ORCID ProfileStephen Todd, View ORCID ProfileKongFatt Wong-Lin, Paula L. McClean
doi: https://doi.org/10.1101/2021.08.03.21261570
Daman Kaur
aNorthern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute, Ulster University, Clinical Translational Research and Innovation Centre (C-TRIC), Altnagelvin Hospital Site, Derry∼Londonderry BT47 6SB, Northern Ireland, UK
Magda Bucholc
bIntelligent Systems Research Centre, School of Computing, Engineering and Intelligent Systems, Ulster University, Northland Rd, Derry∼Londonderry BT48 7JL, Northern Ireland, UK
David P. Finn
cPharmacology and Therapeutics, School of Medicine, Galway Neuroscience Centre, Human Biology Building, National University of Ireland Galway, University Road, Galway H91 W5P7, Republic of Ireland
Stephen Todd
dAltnagelvin Area Hospital, Western Health and Social Care Trust, Derry∼Londonderry BT47 6SB, Northern Ireland, UK
KongFatt Wong-Lin
bIntelligent Systems Research Centre, School of Computing, Engineering and Intelligent Systems, Ulster University, Northland Rd, Derry∼Londonderry BT48 7JL, Northern Ireland, UK
Paula L. McClean
aNorthern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute, Ulster University, Clinical Translational Research and Innovation Centre (C-TRIC), Altnagelvin Hospital Site, Derry∼Londonderry BT47 6SB, Northern Ireland, UK
Posted March 25, 2022.
Impact of different diagnostic measures on drug class association with dementia progression risk: a longitudinal prospective cohort study
Daman Kaur, Magda Bucholc, David P. Finn, Stephen Todd, KongFatt Wong-Lin, Paula L. McClean
medRxiv 2021.08.03.21261570; doi: https://doi.org/10.1101/2021.08.03.21261570
Impact of different diagnostic measures on drug class association with dementia progression risk: a longitudinal prospective cohort study
Daman Kaur, Magda Bucholc, David P. Finn, Stephen Todd, KongFatt Wong-Lin, Paula L. McClean
medRxiv 2021.08.03.21261570; doi: https://doi.org/10.1101/2021.08.03.21261570
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)